All of Us (initiative)

Last updated
All of Us
Headquarters Bethesda, Maryland, United States
Parent organization
 National Institutes of Health (NIH)
Website allofus.nih.gov

The All of Us Research Program (previously known as the Precision Medicine Initiative Cohort Program [1] ) is a research program created in 2015 during the tenure of Barack Obama with $130 million [2] in funding that aims to make advances in tailoring medical care to the individual. [3] The mission of All of Us is to accelerate health and medical breakthroughs, enabling individualized prevention, treatment and care.

Contents

The project aims to collect genetic and health data from one million volunteers. [4] The initiative was announced during the 2015 State of the Union Address, [5] and is run by the National Institutes of Health (NIH). The program is bilingual, with information and materials available in Spanish and English.

Who can enroll

Eligible adults (18 and over) can enroll with the program. People who are not eligible are those in prison or people who cannot consent on their own [6] According to a sample consent form released in June 2018, participation in All of Us is voluntary and does not affect a participant's medical care. The form explains that if a participant quits the program, their samples will be destroyed. [7] Children may also be able to enroll in the program. [8]

By January 2018 an initial pilot project had enrolled about 10,000 people and 2022 was targeted for one million people. [9] As of May 2019, enrollment numbers at the one-year launch anniversary are 187,000+ participants. More than 132,000 have already given biosamples. [10]

The NIH reported in May 2018 that they were pleased with the high enrollment by underrepresented groups including communities of color and individuals with lower incomes. Up to three-quarters of beta phase participants came from those communities. [11] [8]

Program partners

Stanford 2022 Wellness Fair - 18.jpg

All of Us has more than 100 partners and champions working together to implement and support the mission and goals of the research program. [12] Google life sciences startup Verily Life Sciences, a Google "moonshot" with a goal of "transform[ing] the way we detect, prevent, and manage disease" [13] [7] is one partner.

The initiative was identified by a 2019 review as involving the public in every stage of the research. [14]

Program budget

The All of Us Research Program budget has increased every year since it launched: FY2016 - $130 million; FY2017 - $230 million; and FY2018 - $290 million. [15] [16]

Responses to the Initiative

Professor Kenneth Weiss from Pennsylvania State University, in a skeptical review of this project in 2017, suggested that the funding could be better spent elsewhere. [17]

The project suffered backlash in 2024 to their use of umap plotting to depict ancestry, rather than principal components analysis. [18]

Program progress

Enrollment

The research program was launched for national enrollment on May 6, 2018. [11] In the summer of 2019, one year after its official launch, All of Us had enrolled 230,000 participants, which represents almost one quarter of the program's goal of 1,000,000 individuals. Approximately 80% of those people are from groups that have been traditionally underrepresented in biomedical research. One of All of US's main goals is to include many people from diverse ancestries. [19] By June 2020, enrollment reached approximately 350,000 individuals. [20]

All of Us Researcher Workbench

On May 27, 2020, the All of Us research program announced the launch of their research platform, the All of Us Researcher Workbench, for beta testing. Select data collected by the initiative, including electronic health records and survey responses from the first 225,000 program participants, will be available to approved researchers through the workbench. [20] Researchers may apply for access to the data if they have an NIH eRA Commons account (for identity verification) and are affiliated with an institution that has signed a data use agreement with All of Us. [21]

Response to COVID-19 pandemic

In June 2020, the NIH announced that research materials collected as part of the All of Us initiative will be used to address the COVID-19 pandemic. Blood samples collected from recent volunteers will be tested for SARS-CoV-2 antibodies in order to track prior infections within the US population. [22] Electronic health records shared by All of Us participants will also be evaluated for potential patterns associated with SARS-CoV-2 infection. All of Us also added monthly participant surveys with questions about the physical, mental, and socioeconomic impacts of the COVID-19 pandemic. [23]

Administration

The founding program director was Eric Dishman, who stepped down to become the Chief Innovation Officer. [24] In 2019, Joshua Denny was selected to be the second director. [25] In October 2016, the project was renamed "All of Us". [26] [27] [28]

See also

Related Research Articles

<span class="mw-page-title-main">University of California, San Francisco</span> Public university in California, US

The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.

<span class="mw-page-title-main">National Institutes of Health</span> US government medical research agency

The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.

<span class="mw-page-title-main">Women's Health Initiative</span> Long-term U.S. health study

The Women's Health Initiative (WHI) was a series of clinical studies initiated by the U.S. National Institutes of Health (NIH) in 1991, to address major health issues causing morbidity and mortality in postmenopausal women. It consisted of three clinical trials (CT) and an observational study (OS). In particular, randomized controlled trials were designed and funded that addressed cardiovascular disease, cancer, and osteoporosis.

<span class="mw-page-title-main">UK Biobank</span> Long-term biobank study of 500,000 people

UK Biobank is a large long-term biobank study in the United Kingdom (UK) which is investigating the respective contributions of genetic predisposition and environmental exposure to the development of disease. It began in 2006. UK Biobank has been cited as an important resource for cancer research.

<span class="mw-page-title-main">Kathy Giusti</span>

Kathy Giusti is a business leader and a healthcare disrupter. She is a two-time cancer survivor having been diagnosed with multiple myeloma and breast cancer. Kathy Co-Founded the Multiple Myeloma Research Foundation where she served as CEO and president for nearly two decades. She also co-chaired the Harvard Business School (HBS) Kraft Precision Medicine Accelerator, which she helped found, as a Senior Fellow at Harvard Business School.

<span class="mw-page-title-main">HIV Vaccine Trials Network</span>

The HIV Vaccine Trials Network (HVTN) is a non-profit organization which connects physicians and scientists with activists and community educators for the purpose of conducting clinical trials seeking a safe and effective HIV vaccine. Collaboratively, researchers and laypeople review potential vaccines for safety, immune response, and efficacy. The HVTN is a network for testing vaccines, and while its members may also work in vaccine development for other entities, the mission of the HVTN does not include vaccine design.

<span class="mw-page-title-main">University of Wisconsin School of Medicine and Public Health</span> Medical school in the United States

The University of Wisconsin School of Medicine and Public Health (UWSMPH) is a professional school for the study of medicine and public health at the University of Wisconsin–Madison. It is one of only two medical schools in Wisconsin, along with the Medical College of Wisconsin in Milwaukee, and the only public one.

<span class="mw-page-title-main">University of Florida College of Pharmacy</span> Pharmacy school in Gainesville, Florida

The University of Florida College of Pharmacy is the pharmacy school of the University of Florida. The College of Pharmacy was founded in 1923 and is located on the university's Gainesville, Florida main campus. The college offers the entry-level Doctor of Pharmacy (Pharm.D.) degree as the first professional degree for students entering the profession. The college offered a Working Professional Pharm.D. (WPPD) program for bachelor's-trained pharmacists already in practice with its last cohort of students enrolled in 2016. Additionally, various graduate degrees are offered. The professional program is fully accredited by the American Council on Pharmaceutical Education. Since 2011 the college has been offering online degree programs at the graduate level, such as the Forensic Science Program, Pharmaceutical Chemistry Program and Clinical Toxicology Program. In total the College of Pharmacy received over $32 million in total Research Revenues in 2021.

ClinicalTrials.gov is a registry of clinical trials. It is run by the United States National Library of Medicine (NLM) at the National Institutes of Health, and holds registrations from over 444,000 trials from 221 countries.

<span class="mw-page-title-main">Francis Collins</span> American physician-scientist (born 1950)

Francis Sellers Collins is an American physician-scientist who discovered the genes associated with a number of diseases and led the Human Genome Project. He served as director of the National Institutes of Health (NIH) in Bethesda, Maryland, from 17 August 2009 to 19 December 2021, serving under three presidents.

Joe G. N. "Skip" Garcia is an American pulmonary scientist, physician and academician.

<span class="mw-page-title-main">Eric D. Green</span> American science administrator

Eric D. Green is an American genomics researcher who had significant involvement in the Human Genome Project. He is the director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH), a position he has held since 2009.

The Rare Diseases Clinical Research Network (RDCRN) is an initiative of the US Office of Rare Diseases Research (ORDR). RDCRN is funded by the ORDR, the National Center for Advancing Translational Sciences and collaborating institute centers. The RDCRN is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.

The Pancreatic Cancer Action Network (PanCAN) is a United States-based 501(c)(3) charity that funds research, provides patient/caregiver support, conducts community outreach and advocates for increased federal research funding for those affected by pancreatic cancer.

The White House BRAIN Initiative is a collaborative, public-private research initiative announced by the Obama administration on April 2, 2013, with the goal of supporting the development and application of innovative technologies that can create a dynamic understanding of brain function.

<span class="mw-page-title-main">Consuelo H. Wilkins</span>

Consuelo H. Wilkins is an American physician, biomedical researcher, and health equity expert. She is Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence at Vanderbilt University Medical Center. She is a professor of medicine in the Department of Medicine, Division of Geriatrics at Vanderbilt University School of Medicine and has a joint appointment at Meharry Medical College. She additionally serves as one of the principal investigators of the Vanderbilt Clinical and Translational Science Award, Director of the Meharry-Vanderbilt Community Engaged Research Core (CTSA) and as vice president for Health Equity at Vanderbilt University Medical Center.

PrecisionFDA is a secure, collaborative, high-performance computing platform that has established a growing community of experts around the analysis of biological datasets in order to advance precision medicine, inform regulatory science, and enable improvements in health outcomes. This cloud-based platform is developed and served by the United States Food and Drug Administration (FDA). PrecisionFDA connects experts, citizen scientists, and scholars from around the world and provides them with a library of computational tools, workflow features, and reference data. The platform allows researchers to upload and compare data against reference genomes, and execute bioinformatic pipelines. The variant call file (VCF) comparator tool also enables users to compare their genetic test results to reference genomes. The platform's code is open source and available on GitHub. The platform also features a crowdsourcing model to sponsor community challenges in order to stimulate the development of innovative analytics that inform precision medicine and regulatory science. Community members from around the world come together to participate in scientific challenges, solving problems that demonstrate the effectiveness of their tools, testing the capabilities of the platform, sharing their results, and engaging the community in discussions. Globally, precisionFDA has more than 5,000 users.

<span class="mw-page-title-main">21st Century Cures Act</span> Bill enacted by the 114th United States Congress

The 21st Century Cures Act is a United States law enacted by the 114th United States Congress in December 2016 and then signed into law on December 13, 2016. It authorized $6.3 billion in funding, mostly for the National Institutes of Health. The act was supported especially by large pharmaceutical manufacturers and was opposed especially by some consumer organizations.

<span class="mw-page-title-main">Elizabeth Mayer-Davis</span> American nutritionist and academic

Elizabeth "Beth" Mayer-Davis is an American nutritionist who is the Cary C. Boshamer Distinguished Professor at the UNC Gillings School of Global Public Health. She is the Director of the University of North Carolina at Chapel Hill Nutrition Obesity Research Center, and Dean of the UNC Graduate School. She has sought to better understand diabetes. She was awarded the 2019 American Diabetes Association Kelly West Award.

References

  1. ↑ "FACT SHEET: President Obama's Precision Medicine Initiative". whitehouse.gov . 2015-01-30. Retrieved 2 May 2019– via National Archives.
  2. ↑ "About the All of Us Research Program" . Retrieved 2 May 2019.
  3. ↑ "FACT SHEET: President Obama's Precision Medicine Initiative". whitehouse.gov. 30 January 2015. Retrieved 26 July 2016– via National Archives.
  4. ↑ Reardon, Sara (1 September 2015). "Giant study poses DNA data-sharing dilemma". Nature .
  5. ↑ Dvorsky, George (21 January 2015). "How Obama's Precision Medicine Initiative Will Revolutionize Healthcare". io9 .
  6. ↑ "Who Can Join?" . Retrieved 3 May 2019.
  7. 1 2 "Verily, Google's bold bid to transform medicine, hits turbulence under a divisive CEO". March 28, 2016.
  8. 1 2 "How The All of Us Research is Restoring Trust and Bringing A Much-Needed Diversity to Medical Research". 2019-04-10. Retrieved 2 May 2019.
  9. ↑ Cunningham, Paige Winfield (16 January 2018). "The Health 202: NIH wants 1 million Americans to contribute to new pool of gene data". Washington Post. ISSN   0190-8286 . Retrieved 20 January 2018.
  10. ↑ "All of Us Research Hub" . Retrieved 2 May 2019.
  11. 1 2 says, Kathleen Flanagan-Olson (May 1, 2018). "NIH opens nationwide enrollment for huge precision medicine initiative".
  12. ↑ "All of Us Program Partners" . Retrieved 2 May 2019.
  13. ↑ Kaiser, Jocelyn (25 February 2016). "NIH's 1-million-volunteer precision medicine study announces first pilot projects". Science .
  14. ↑ Lacaze, Paul; Fransquet, Peter; Tiller, Jane; Nunn, Jack S. (2019). "Public Involvement in Global Genomics Research: A Scoping Review". Frontiers in Public Health. 7: 79. doi: 10.3389/fpubh.2019.00079 . ISSN   2296-2565. PMC   6467093 . PMID   31024880.
  15. ↑ "All of Us Research Program Backgrounder" . Retrieved 2 May 2019.
  16. ↑ Molteni, Megan (6 May 2018). "The NIH Launches Its Ambitious Million-Person Genetic Survey". Wired .
  17. ↑ Weiss, Kenneth M. (Fall 2017). "Is Precision Medicine Possible?". Issues in Science and Technology. 34 (1). Retrieved 20 January 2018.
  18. ↑ pachter, lior (2024-02-26). "all of us failed". wordpress. Retrieved 2024-03-08. all of us failed
  19. ↑ "One Year After Launch, NIH's All of Us Hits Key Milestones". 19 August 2019.
  20. 1 2 HealthITAnalytics (2020-06-01). ""All of Us" Opens Precision Medicine Data Platform for Beta Testing". HealthITAnalytics. Retrieved 2020-06-17.
  21. ↑ "All of Us Research Program Begins Beta Testing of Data Platform | National Institutes of Health (NIH) — All of Us". allofus.nih.gov. Retrieved 2020-06-17.
  22. ↑ "NIH launches COVID-19 tracking initiatives through 'All of Us' precision medicine program". www.beckershospitalreview.com. Retrieved 2020-06-17.
  23. ↑ "NIH Musters Million-Person Study to Track Covid's Spread". news.bloomberglaw.com. Retrieved 2020-06-17.
  24. ↑ "Statement from Eric Dishman on Changing Leadership at the NIH All of Us Research Program". National Institutes of Health (NIH) — All of Us. 2020-08-21. Retrieved 2021-10-17.
  25. ↑ "Selection of Dr. Joshua Denny as Chief Executive Officer of the All of Us Research Program | National Institutes of Health (NIH) — All of Us". allofus.nih.gov. Retrieved 2020-02-08.
  26. ↑ "All of Us (project web page)". U.S. Department of Health & Human Services - National Institutes of Health. 2018. Retrieved 20 January 2018.
  27. ↑ Muoio, Dave (7 November 2017). "Fitbit wearables will help power NIH's All of Us Research Program". MobiHealthNews. Retrieved 20 January 2018.
  28. ↑ "NIH Partners With 14 Community Groups, Healthcare Associations on Outreach for All of Us Program". GenomeWeb. 17 November 2017. Retrieved 20 January 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.